Bile acids are crucial regulators of insulin sensitivity, glucolipid metabolism and immune response, which contribute to the pathogenesis of NAFLD by regulating FXR and Takeda G-protein receptor 5 (TGR5) (3). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.